Works cited by this work

25 works

Work: Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries              

1. Home visits: a strategy to improve newborn survival - Authors' reply

   Kirkwood, B, Humphrey, J, Moulton, L +1

   Article200821 citations

   ABIABI:AkademIndex/openalex/2026.other.222975

2. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

   Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin +26

   Article20208 citations

   ABIABI:AkademIndex/openalex/2026.other.373862

3. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

   Denis Y. Logunov, Inna V. Dolzhikova, Dmitry V. Shcheblyakov +28

   Article20215 citations

   ABIABI:AkademIndex/openalex/2026.other.554498

4. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis

   Derek K. Chu, Elie A Akl, Stephanie Duda +39

   Review article20204 citations

   ABIABI:AkademIndex/openalex/2026.other.405791

5. Recombinant vaccines for COVID-19

   Tushar Yadav, Nishant Srivastava, Gourav Mishra +4

   Review article20203 citations

   ABIABI:AkademIndex/openalex/2026.other.554492

6. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

   Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi +97

   Article20203 citations

   ABIABI:AkademIndex/openalex/2026.other.554494

7. International Ethical Guidelines for Health-related Research involving Humans

   Council for International Organizations of Medical Sciences (CIOMS)

   Report20163 citations

   ABIABI:AkademIndex/openalex/2026.other.554504

8. The ethics of ‘public understanding of ethics’—why and how bioethics expertise should include public and patients’ voices

   Silke Schicktanz, Mark Schweda, Brian Wynne

   Article20112 citations

   ABIABI:AkademIndex/openalex/2026.other.554486

9. Opinion summarization methods: Comparing and extending extractive and abstractive approaches

   Roque López, Thiago Alexandre Salgueiro Pardo

   Article20172 citations

   ABIABI:AkademIndex/openalex/2026.other.554487

10. Vaccine Efficacy Needed for a COVID-19 Coronavirus Vaccine to Prevent or Stop an Epidemic as the Sole Intervention

    Sarah M. Bartsch, Kelly J. O’Shea, Marie C. Ferguson +8

    Article20202 citations

    ABIABI:AkademIndex/openalex/2026.other.554488

11. Good reasons to vaccinate: mandatory or payment for risk?

    Julian Savulescu

    Article20202 citations

    ABIABI:AkademIndex/openalex/2026.other.554489

12. COVID-19 response in central Asia

    Vijay Shankar Balakrishnan

    Article20202 citations

    ABIABI:AkademIndex/openalex/2026.other.554490

13. Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination

    Roy M. Anderson, Carolin Vegvari, James E. Truscott +1

    Article20202 citations

    ABIABI:AkademIndex/openalex/2026.other.554491

14. Ethical allocation of future COVID-19 vaccines

    Rohit Gupta, Stephanie R. Morain

    Article20202 citations

    ABIABI:AkademIndex/openalex/2026.other.554495

15. COVID-19 mortality risk assessment: An international multi-center study

    Dimitris Bertsimas, Galit Lukin, Luca Mingardi +16

    Article20202 citations

    ABIABI:AkademIndex/openalex/2026.other.554496

16. Covax must go beyond proportional allocation of covid vaccines to ensure fair and equitable access

    Lisa Herzog, Ole Frithjof Norheim, Ezekiel Emanuel +1

    Article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.554497

17. Just allocation of COVID-19 vaccines

    Anders Herlitz, Zohar Lederman, Jennifer Miller +5

    Article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.554499

18. Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

    Olivier J. Wouters, Kenneth C. Shadlen, Maximilian Salcher‐Konrad +4

    Review article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.554500

19. Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

    Robert Challen, Ellen Brooks‐Pollock, Jonathan M. Read +3

    Article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.554501

20. WHO’s allocation framework for COVAX: is it fair?

    Siddhanth Sharma, Nisrine Kawa, Apoorva Gomber

    Article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.554502

21. How long does covid-19 immunity last?

    Chris Baraniuk

    Article20212 citations

    ABIABI:AkademIndex/openalex/2026.other.554503

22. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.686156

23. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.686157

24. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.686158

25. Untitled

    Other1 citations

    ABIABI:AkademIndex/openalex/2026.other.686159